Toggle Main Menu Toggle Search

Open Access padlockePrints

A phase II study of AMN107, a novel inhibitor of Bcr-Abl, administered to imatinib resistant and intolerant patients (pts) with chronic myelogenous leukemia (CML) in chronic phase (CP)

Lookup NU author(s): Professor Stephen O'Brien


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Kantarjian HM, Gattermann N, O'Brien SG, Bhalla K, Hochhaus A, Cervantes F, Alland L, Ottmann O, Giles F, Le Coutre P

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 42nd Meeting of the American Society of Clinical Oncology

Year of Conference: 2006

Pages: 345S-345S

Publisher: Journal of Clinical Oncology: American Society of Clinical Oncology

Library holdings: Search Newcastle University Library for this item